Reduced NT-proBNP levels at 4 weeks was indicative of a lower risk of HF re-hospitalization and CV death (hazard ratio: 0.57; 95% confidence interval (CI): 0.38–0.86; p = 0.007). This evidence concerns the gene NPPB and hydrops fetalis.